Tachyon Ventures
Venture capitalLos Angeles Β· Pre-SeedβSeries A Β· 2 people tracked
Investment thesis
Tachyon focuses on early-stage investment in disruptive scientific platforms across biology and medicine. The firm believes it can price scientific risk earlier than others by identifying strong science early and assessing its potential across development stages. It maximizes upside by backing disruptive platforms early while mitigating risk through a focus on world-class research with protected intellectual property. Tachyon backs teams with world-leading published research who are recognized leaders in their fields, and invests in companies with protected IP developed by or in collaboration with their scientific co-founders. It draws on a network of knowledgeable scientists at top research institutions.
Source: firm website, verified Aug 3, 2026.
Team Β· 2 people
from the firm's website
What they invest in
from 11 of 18 portfolio companiesBiotech Γ11Medical Devices Γ5AI & Machine Learning Γ4Deep Tech Γ4Digital Health Γ3Healthtech Γ3
HQs:United StatesΓ7
Investments Β· 18 tracked
founders shown can be your intro pathAbsci uses AI and wet lab research in iterative cycles to design novel antibody therapeutics and biologics for drug discovery.
AI & Machine LearningBiotechDeep TechPortland, US
Zach Jonasson(Director)Bryan Lawlis(Director)Phil Barish(Executive Officer)Daniel Gold(Director)Sean McClain(Executive Officer)
AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry.
AI & Machine LearningBiotechDeep Tech
Altay Therapeutics develops small molecule inhibitors targeting transcription factors to treat serious diseases including facioscapulohumeral muscular dystrophy and cancer.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Axonis Therapeutics develops medicines targeting KCC2 to restore inhibition in the brain, with a focus on treating neurological disorders including epilepsy and pain.
BiotechMedical DevicesBoston, US
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical Devices<UNKNOWN>, US
Nina Tandon(Co-Founder, CEO)Sarindr Bhumiratana(Co-Founder)Robert Langer(Director)Gordana Vunjak-Novakovic(Director)David Zhu(Director)
Mammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
BiotechDeep TechMedical DevicesBrisbane, US
Jennifer Doudna(Founder)inTrevor Martin(Co-founder, Chief Executive Officer)Janice Chen(Co-founder, Chief Scientific Officer & President, Research)Lucas Harrington(Co-founder)inUrshit Parikh(Director)Ashley Tehranchi(Executive Officer, Director)
BiotechPittsburg, US
Stephan Dietrich(Director)Jonathan Steckbeck(Executive Officer, Director)
Scipher Medicine develops a precision immunology platform using AI and molecular data to match immunological disease patients with their most effective therapies.
AI & Machine LearningBiotechDigital Health
Stylus Medicine develops in vivo genetic medicines using engineered recombinases, with initial focus on creating CAR-T therapies delivered via lipid nanoparticles for oncology, autoimmune, and genetic diseases.
BiotechDigital HealthMedical Devices
Michael C. Bassik, Ph.D.(Scientific Founder)inEmile Nuwaysir, Ph.D.(Chairman & Chief Executive Officer)inJason Fontenot, Ph.D.(Chief Scientific Officer)
Valo combines AI, causal inference techniques, and chemistry to accelerate drug discovery and development by identifying disease targets in human data and rapidly engineering novel small molecules.
AI & Machine LearningBiotechDeep Tech
Frequently asked questions
- What stage does Tachyon Ventures invest at?
- Tachyon Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Tachyon Ventures focus on?
- Tachyon Ventures focuses on Biotech, Deep Tech, Medical Devices.
- Where is Tachyon Ventures located?
- Tachyon Ventures is headquartered in Los Angeles, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Investinor AS is a Norwegian investment company that partners with founders, entrepreneurs and other investors to help selected promising companies become world-leading.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.